Nurofen Migrxpress 400mg 12 tablets.
100% secure payment
Shipping and Postage
Deliveries within 24-48 working hours for products available in stock. Shipping from €3.99 and free on purchases >€40, for PT Continental. Returns? Find out more here .
Nurofen Migrxpress contains 684 mg of ibuprofen lysinate, which is equivalent to 400 mg of ibuprofen. Ibuprofen belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). These medicines provide relief by changing the way the body reacts to pain, swelling and high temperature. Its composition of ibuprofen lysinate ensures rapid absorption and effectiveness. Nurofen Migrxpress is used in adults to treat the following conditions:
- Mild to moderate pain
- Headaches
- Migraines
- Toothache
- Menstrual pain
- Muscle pain
- Rheumatic pain
- Back pain
- Neuralgia
- Cold and Flu Symptoms
- Symptomatic treatment of fever lasting less than 3 days.
How to Use
- Adults: 1 tablet every 8 hours (3x/day).
- It should not be administered to children under 18 years of age without a doctor's recommendation. There are other formulations that are more suitable for children under 18 years of age.
- Do not exceed the recommended dose. If you take the maximum dose, you should wait at least 8 hours before taking another dose.
Keep this medicine out of the sight and reach of children. Nurofen Migrxpress 400 mg coated tablets (adults) is a non-prescription medicine dispensed exclusively in pharmacies indicated for the symptomatic treatment of mild to moderate pain and fever. Do not take this medicine if you are hypersensitive to the medicine, any of the excipients or other NSAIDs. Take special care if you have a history of gastrointestinal bleeding or perforation, active peptic ulcer/bleeding, are taking medicines that may increase the risk of ulceration/bleeding, cerebrovascular haemorrhage, high blood pressure, asthma/allergic disease, nasal polyps or chronic obstructive pulmonary disease, therapy-related bronchospasm, rhinitis and urticaria, severe liver, kidney or heart failure, blood clotting disorders, problems with blood cell production, significant dehydration, congenital disorder of porphyrin metabolism, chronic alcoholism, systemic lupus erythematosus/mixed connective tissue disease, bowel disease, have recently undergone major surgery, are pregnant or breast-feeding. For more information, see the information leaflet here .